By continuing to use the site, you agree to our use of cookies and to abide by our Terms and Conditions. We in turn value your personal details in accordance with our Privacy Policy.
Please log in or register. Registered visitors get fewer ads.
Another interesting development with regards to mRNA vaccines. Moderna has made personal mRNA vaccines as an accompinant to it's existing melanoma treatments which saw a 44% reduction in patients either dying of their cancer or having the cancer progress.
It's another insight into the possible future usages of this technology which should hopefully be helpful to people going forward.
There are a couple of caveats:
- It's expensive in it's current form as the mRNA vaccine has to be tailored to each individual. - The study hasn't had a full peer review yet.